Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · Real-Time Price · USD
2.370
-0.120 (-4.82%)
Dec 20, 2024, 4:00 PM EST - Market closed
Oramed Pharmaceuticals Analyst Ratings
Total Analysts
1
Consensus Rating
Hold
Price Target
n/a
Upside
n/a
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 20, 2024 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $3 → $2 | Hold | Maintains | $3 → $2 | -15.61% | May 17, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jan 17, 2023 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jan 12, 2023 |
| Aegis Capital | Aegis Capital | Strong Buy Maintains $35 → $30 | Strong Buy | Maintains | $35 → $30 | +1,165.82% | May 16, 2022 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $20 | Buy | Initiates | $20 | +743.88% | Feb 18, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $17 → $32 | Strong Buy | Maintains | $17 → $32 | +1,250.21% | Nov 30, 2021 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $17 → $32 | Strong Buy | Maintains | $17 → $32 | +1,250.21% | Nov 29, 2021 |
| Aegis Capital | Aegis Capital | Strong Buy Maintains $20 → $35 | Strong Buy | Maintains | $20 → $35 | +1,376.79% | Nov 2, 2021 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $27 → $30 | Strong Buy | Maintains | $27 → $30 | +1,165.82% | Jul 29, 2021 |
| Aegis Capital | Aegis Capital | Strong Buy Maintains $12 → $20 | Strong Buy | Maintains | $12 → $20 | +743.88% | Jun 8, 2021 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $27 | Strong Buy | Initiates | $27 | +1,039.24% | Apr 20, 2021 |
| Aegis Capital | Aegis Capital | Strong Buy Maintains $6 → $12 | Strong Buy | Maintains | $6 → $12 | +406.33% | Jan 27, 2021 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 → $17 | Strong Buy | Reiterates | $16 → $17 | +617.30% | Jul 13, 2020 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $20 → $16 | Strong Buy | Maintains | $20 → $16 | +575.11% | Jun 22, 2020 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.